Prevalence of overweight, central obesity and metabolic comorbidities risk in adults living with HIV/AIDS

Detalhes bibliográficos
Autor(a) principal: Guimarães, Nathalia Sernizon
Data de Publicação: 2016
Outros Autores: Fausto, Maria Arlene, Tupinambás, Unaí
Tipo de documento: Artigo
Idioma: por
eng
Título da fonte: Revista Brasileira em Promoção da Saúde
Texto Completo: https://ojs.unifor.br/RBPS/article/view/4286
Resumo: Objetive: To describe the prevalence of overweight, central obesity and risk of metabolic comorbidities in people living with HIV/AIDS, without antiretroviral (ARV) therapy. Methods: Observational, cross-sectional, descriptive study held in an Infectious and Parasitic Diseases Referral Treatment Center of Belo Horizonte, MG, with adults with HIV/AIDS, who had not initiated ARV therapy. The study collected information on weight, height, Body Mass Index (BMI) and waist circumference (WC). Food intake was investigated through the application of 24-hour dietary recall. Additionally, a questionnaire was used to collect socioeconomic data. Results: Of the 100 volunteers, 76% were men with average age of 37.1 years. Approximately one third had CD4 ≤ 200 and 64% were classified as sedentary. Men had higher mean weight (71.6 kg against 59.9 kg) and height (1.72m against 1.60m) compared to women. Weight excess and central obesity prevalences of were 4.1% and 35.7%, respectively. Substantially increased metabolic comorbidities risk was present in 20.4% of the subjects. Half of the sample consumed large amounts of processed foods and registered low consumption of fruits and vegetables. Conclusion: Before initiating the ARV therapy, the individuals with HIV/AIDS already presented overweight, central obesity, and consequent risk of metabolic comorbidities. Therefore, health education interventions prior to the ARV therapy are necessary for primary prevention of future metabolic problems.
id UFOR-2_7b7ad15f3df5e89b6938999294303457
oai_identifier_str oai:ojs.ojs.unifor.br:article/4286
network_acronym_str UFOR-2
network_name_str Revista Brasileira em Promoção da Saúde
repository_id_str
spelling Prevalence of overweight, central obesity and metabolic comorbidities risk in adults living with HIV/AIDSPrevalencia del exceso de peso, obesidad central y riesgo de comorbidades metabólicas en adultos con VIH/AIDS sin terapia antirretroviralPrevalência de excesso de peso, obesidade central e risco de comorbidades metabólicas em adultos com HIV/AIDS sem terapia antirretroviralObesityAnthropometryPrevalenceHIV.ObesidadAntropometríaPrevalenciaVIH.ObesidadeAntropometriaPrevalênciaHIV.Objetive: To describe the prevalence of overweight, central obesity and risk of metabolic comorbidities in people living with HIV/AIDS, without antiretroviral (ARV) therapy. Methods: Observational, cross-sectional, descriptive study held in an Infectious and Parasitic Diseases Referral Treatment Center of Belo Horizonte, MG, with adults with HIV/AIDS, who had not initiated ARV therapy. The study collected information on weight, height, Body Mass Index (BMI) and waist circumference (WC). Food intake was investigated through the application of 24-hour dietary recall. Additionally, a questionnaire was used to collect socioeconomic data. Results: Of the 100 volunteers, 76% were men with average age of 37.1 years. Approximately one third had CD4 ≤ 200 and 64% were classified as sedentary. Men had higher mean weight (71.6 kg against 59.9 kg) and height (1.72m against 1.60m) compared to women. Weight excess and central obesity prevalences of were 4.1% and 35.7%, respectively. Substantially increased metabolic comorbidities risk was present in 20.4% of the subjects. Half of the sample consumed large amounts of processed foods and registered low consumption of fruits and vegetables. Conclusion: Before initiating the ARV therapy, the individuals with HIV/AIDS already presented overweight, central obesity, and consequent risk of metabolic comorbidities. Therefore, health education interventions prior to the ARV therapy are necessary for primary prevention of future metabolic problems.Objetivo: Describir la prevalencia del exceso de peso, la obesidad central y el riesgo de comorbidades metabólicas en adultos com VIH/AIDS sin terapia antirretroviral (ARV). Métodos: Estudio observacional, transversal y descriptivo realizado en un Centro de Tratamiento y Referencia en Enfermedades Infecciosas y Parasitarias de Belo Horizonte, MG, con adultos con VIH/ AIDS que no habían iniciado el tratamiento antirretroviral. Se recogieron informaciones sobre el peso, la altura, el Índice de Masa Corporal (IMC) y la circunferencia abdominal (CA). La ingesta alimentaria fue investigada a través de la aplicación de un recordatorio de 24 horas. Además, se utilizó una encuesta para recoger datos socioeconómicos. Resultados: De los 100 voluntarios, el 76% eran hombres con una media de edad igual a 37,1 años. Aproximadamente un tercio presentó CD4 ≤ 200 y el 64% se presentaron como sedentarios. Los hombres presentaron mayores medias de peso (71,6 Kg versus 59,9 Kg) y altura (1,72 m versus 1,60 m) en comparación a las mujeres. Las prevalências del exceso de peso y obesidad central fueron iguales al 4,1% y al 35,7%, respectivamente. El riesgo de comorbidades metabólicas se presentó muy elevado en el 20,4% de los individuos. La mitad de la muestra consumía gran cantidad de alimentos industrializados y bajo consumo de frutas, verduras y legumbres. Conclusión: Antes del inicio de la terapia ARV, los individuos con VIH/AIDS ya presentaban exceso de peso, obesidad central y consecuente riesgo de comorbidades metabólicas. Por lo tanto, son necesarias intervenciones de educación en salud antes de la terapia com ARV para la prevención primaria de problemas metabólicos em el futuro.Objetivo: Descrever a prevalência de excesso de peso, obesidade central e risco de comorbidades metabólicas em adultos com HIV/AIDS, sem terapia antirretroviral (ARV). Métodos: Estudo observacional, transversal, descritivo realizado em um Centro de Tratamento e Referência em Doenças Infecto-Parasitarias de Belo Horizonte, MG, com adultos com HIV/AIDS que não iniciaram o tratamento antirretroviral. Foram coletadas informações sobre o peso, altura, Índice de Massa Corporal (IMC) e circunferência abdominal (CA). A ingestão alimentar foi investigada por meio da aplicação de recordatório alimentar de 24 horas. Além disso, um questionário foi usado para coleta dos dados socioeconômicos. Resultados: Dos 100 voluntários, 76% eram homens com idade média igual a 37,1 anos. Aproximadamente um terço apresentou CD4 ≤ 200 e 64% denominaram-se como sedentários. Homens apresentaram maiores médias de peso (71,6 Kg versus 59,9 Kg) e altura (1,72 m versus 1,60 m) em comparação às mulheres. As prevalências de excesso de peso e obesidade central foram iguais a 4,1% e 35,7%, respectivamente. Risco de comorbidades metabólicas aumentado substancialmente esteve presente em 20,4% dos indivíduos. Metade da amostra consumia grande quantidade de alimentos industrializados e baixo consumo de frutas, verduras e legumes. Conclusão: Antes de iniciar a terapia ARV, os indivíduos com HIV/AIDS já apresentavam excesso de peso, obesidade central e consequente risco de comorbidades metabólicas. Portanto, são necessárias intervenções de educação em saúde pregressa à terapia com ARV, para prevenção primária de problemas metabólicos futuros.Universidade de Fortaleza2016-09-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion"Peer-reviewed Article""Avaliado pelos pares""Avaliado pelos pares"application/pdfapplication/pdfhttps://ojs.unifor.br/RBPS/article/view/428610.5020/18061230.2016.p399Brazilian Journal in Health Promotion; Vol. 29 No. 3 (2016); 399-405Revista Brasileña en Promoción de la Salud; Vol. 29 Núm. 3 (2016); 399-405Revista Brasileira em Promoção da Saúde; v. 29 n. 3 (2016); 399-4051806-1230reponame:Revista Brasileira em Promoção da Saúdeinstname:Universidade de Fortaleza (Unifor)instacron:UFORporenghttps://ojs.unifor.br/RBPS/article/view/4286/pdfhttps://ojs.unifor.br/RBPS/article/view/4286/pdf_1Copyright (c) 2016 Revista Brasileira em Promoção da Saúdeinfo:eu-repo/semantics/openAccessGuimarães, Nathalia SernizonFausto, Maria ArleneTupinambás, Unaí2022-02-16T12:34:43Zoai:ojs.ojs.unifor.br:article/4286Revistahttps://periodicos.unifor.br/RBPS/oai1806-12301806-1222opendoar:2022-02-16T12:34:43Revista Brasileira em Promoção da Saúde - Universidade de Fortaleza (Unifor)false
dc.title.none.fl_str_mv Prevalence of overweight, central obesity and metabolic comorbidities risk in adults living with HIV/AIDS
Prevalencia del exceso de peso, obesidad central y riesgo de comorbidades metabólicas en adultos con VIH/AIDS sin terapia antirretroviral
Prevalência de excesso de peso, obesidade central e risco de comorbidades metabólicas em adultos com HIV/AIDS sem terapia antirretroviral
title Prevalence of overweight, central obesity and metabolic comorbidities risk in adults living with HIV/AIDS
spellingShingle Prevalence of overweight, central obesity and metabolic comorbidities risk in adults living with HIV/AIDS
Guimarães, Nathalia Sernizon
Obesity
Anthropometry
Prevalence
HIV.
Obesidad
Antropometría
Prevalencia
VIH.
Obesidade
Antropometria
Prevalência
HIV.
title_short Prevalence of overweight, central obesity and metabolic comorbidities risk in adults living with HIV/AIDS
title_full Prevalence of overweight, central obesity and metabolic comorbidities risk in adults living with HIV/AIDS
title_fullStr Prevalence of overweight, central obesity and metabolic comorbidities risk in adults living with HIV/AIDS
title_full_unstemmed Prevalence of overweight, central obesity and metabolic comorbidities risk in adults living with HIV/AIDS
title_sort Prevalence of overweight, central obesity and metabolic comorbidities risk in adults living with HIV/AIDS
author Guimarães, Nathalia Sernizon
author_facet Guimarães, Nathalia Sernizon
Fausto, Maria Arlene
Tupinambás, Unaí
author_role author
author2 Fausto, Maria Arlene
Tupinambás, Unaí
author2_role author
author
dc.contributor.author.fl_str_mv Guimarães, Nathalia Sernizon
Fausto, Maria Arlene
Tupinambás, Unaí
dc.subject.por.fl_str_mv Obesity
Anthropometry
Prevalence
HIV.
Obesidad
Antropometría
Prevalencia
VIH.
Obesidade
Antropometria
Prevalência
HIV.
topic Obesity
Anthropometry
Prevalence
HIV.
Obesidad
Antropometría
Prevalencia
VIH.
Obesidade
Antropometria
Prevalência
HIV.
description Objetive: To describe the prevalence of overweight, central obesity and risk of metabolic comorbidities in people living with HIV/AIDS, without antiretroviral (ARV) therapy. Methods: Observational, cross-sectional, descriptive study held in an Infectious and Parasitic Diseases Referral Treatment Center of Belo Horizonte, MG, with adults with HIV/AIDS, who had not initiated ARV therapy. The study collected information on weight, height, Body Mass Index (BMI) and waist circumference (WC). Food intake was investigated through the application of 24-hour dietary recall. Additionally, a questionnaire was used to collect socioeconomic data. Results: Of the 100 volunteers, 76% were men with average age of 37.1 years. Approximately one third had CD4 ≤ 200 and 64% were classified as sedentary. Men had higher mean weight (71.6 kg against 59.9 kg) and height (1.72m against 1.60m) compared to women. Weight excess and central obesity prevalences of were 4.1% and 35.7%, respectively. Substantially increased metabolic comorbidities risk was present in 20.4% of the subjects. Half of the sample consumed large amounts of processed foods and registered low consumption of fruits and vegetables. Conclusion: Before initiating the ARV therapy, the individuals with HIV/AIDS already presented overweight, central obesity, and consequent risk of metabolic comorbidities. Therefore, health education interventions prior to the ARV therapy are necessary for primary prevention of future metabolic problems.
publishDate 2016
dc.date.none.fl_str_mv 2016-09-30
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
"Peer-reviewed Article"
"Avaliado pelos pares"
"Avaliado pelos pares"
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://ojs.unifor.br/RBPS/article/view/4286
10.5020/18061230.2016.p399
url https://ojs.unifor.br/RBPS/article/view/4286
identifier_str_mv 10.5020/18061230.2016.p399
dc.language.iso.fl_str_mv por
eng
language por
eng
dc.relation.none.fl_str_mv https://ojs.unifor.br/RBPS/article/view/4286/pdf
https://ojs.unifor.br/RBPS/article/view/4286/pdf_1
dc.rights.driver.fl_str_mv Copyright (c) 2016 Revista Brasileira em Promoção da Saúde
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2016 Revista Brasileira em Promoção da Saúde
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Universidade de Fortaleza
publisher.none.fl_str_mv Universidade de Fortaleza
dc.source.none.fl_str_mv Brazilian Journal in Health Promotion; Vol. 29 No. 3 (2016); 399-405
Revista Brasileña en Promoción de la Salud; Vol. 29 Núm. 3 (2016); 399-405
Revista Brasileira em Promoção da Saúde; v. 29 n. 3 (2016); 399-405
1806-1230
reponame:Revista Brasileira em Promoção da Saúde
instname:Universidade de Fortaleza (Unifor)
instacron:UFOR
instname_str Universidade de Fortaleza (Unifor)
instacron_str UFOR
institution UFOR
reponame_str Revista Brasileira em Promoção da Saúde
collection Revista Brasileira em Promoção da Saúde
repository.name.fl_str_mv Revista Brasileira em Promoção da Saúde - Universidade de Fortaleza (Unifor)
repository.mail.fl_str_mv
_version_ 1808844181438726144